Stock Price
8.70
Daily Change
0.28 3.33%
Monthly
6.23%
Yearly
6.23%
Q1 Forecast
8.43

Novavax reported $13.51M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Adma Biologics USD 196.67M 5.21M Sep/2025
AstraZeneca USD 6.59B 126M Sep/2025
BioCryst Pharmaceuticals USD 5.23M 188K Sep/2025
Geron USD 95.42M 26.3M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
MannKind USD 26.97M 1.52M Sep/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novavax USD 13.51M 3.27M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025